Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Confidence in the scientific community declined among U.S. adults in 2022, a major survey shows, driven by a partisan divide in views of both science and medicine that emerged during the COVID-19 pandemic.
The American Cancer Society estimates that over 20,000 new cancer cases in Connecticut this year alone. But there's a concerning shortage of chemotherapy drugs in the state and across the country. News 12 reporter Mark Sudol tells us why and what can be done.
A jury in Oregon says the electric utility PacifiCorp must pay punitive damages for causing devastating wildfires in 2020 — on top of an earlier verdict already expected to amount to billions of dollars.
Pfizer is warning that an antibiotic used to treat syphilis and other bacterial infections in young people are likely to run out by the end of this quarter.
Be Well: Alex Rodriguez on the Importance of Dental Hygiene Following Gum Disease Diagnosis
Be Well: Key Stretches to Consider Before Your Workout
A scientist at the University of California, Riverside is designing an emoji-based measurement system to aid communication between patients and doctors, arguing they could be particularly useful for patients who cannot speak.
Thousands of dead fish washed up ashore in southwest Texas.
Only 1 in 4 residential treatment centers for teens offers a recommended medicine for opioid addiction, according to a study that exposes an important gap in care.
Be Well: Understanding Infertility and Weighing Options to Start a Family
